Prognosis of synchronous endometrial and ovarian cancer based on the PROMISE molecular system

Ming Wang, Wang M, Yue Li, Li Y, Jianqing Xu, Xu J, Xu S, Shuiqing Xu, Yumei Wu, Wu Y
Chinese medical journal · 2024 · vol. 137(15) , pp. 1870–1872 · doi:10.1097/cm9.0000000000003062 · PMID:38867410 · PMC12077555
Other OA: gold CC-BY-NC-ND-4.0
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-21 ⓘ

This study evaluated the prognostic capabilities of the PROMISE molecular system for synchronous endometrial and ovarian cancers.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Endometrial Neoplasms Endometrial Neoplasms Endometrial Neoplasms Ovarian Neoplasms Ovarian Neoplasms Ovarian Neoplasms Ovarian Neoplasms Female Humans Prognosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-10-11T09:27:45.537177+00:00
pubmed
last seen: 2026-10-08T21:44:23.379930+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-NC-ND-4.0